Monte Rosa Therapeutics (GLUE) Schedule 13G Reports 7.7% Stake

Monte Rosa Therapeutics, Inc. received a joint Schedule 13G filing showing that Dimension Capital I, L.P. and affiliated reporting persons collectively beneficially hold 4,757,563 shares of the issuer's common stock, representing 7.7% of the class.

Rhea-AI Filing Summary

Monte Rosa Therapeutics, Inc. received a joint Schedule 13G filing showing that Dimension Capital I, L.P. and affiliated reporting persons collectively beneficially hold 4,757,563 shares of the issuer's common stock, representing 7.7% of the class. The filing lists the reporting persons as Dimension Management, L.P., Dimension Capital I GP, LLC, Dimension Management GP, LLC, Dimension Capital I, L.P. and individuals Adam Goulburn, Zavain Dar, and Nan Li. The cover information states the ownership percentages are calculated using 61,759,350 outstanding shares reported by the issuer as of August 1, 2025. The reporting persons disclose shared voting and dispositive power over the disclosed shares and certify the shares were not acquired to change control of the company.

Positive

• 4,757,563 shares disclosed provides transparent ownership detail
• 7.7% stake exceeds 5% threshold, triggering public disclosure
• Ownership calculation tied to 61,759,350 outstanding shares as of August 1, 2025

Negative

• None.

Insights

Securities Ownership Analyst

TL;DR: A passive investor group reports a 7.7% beneficial stake in Monte Rosa (GLUE).

The Schedule 13G shows Dimension Capital I, L.P. directly holds 4,757,563 shares, with shared voting and dispositive power allocated across affiliated entities and three named individuals.

This filing is structured as a passive Schedule 13G and includes a certification that the holdings were not acquired to influence control; that classification is relevant to how investors interpret intent and regulatory obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake in Monte Rosa (GLUE) is disclosed in this Schedule 13G?

The filing discloses a beneficial ownership of 4,757,563 shares, equal to 7.7% of outstanding common stock.

Who are the reporting parties named on the filing for GLUE?

Reporting persons include Dimension Capital I, L.P., Dimension Management, L.P., Dimension Capital I GP, LLC, Dimension Management GP, LLC, and individuals Adam Goulburn, Zavain Dar, and Nan Li.

What voting or dispositive power is reported?

The filing reports 0 sole voting/dispositive power and 4,757,563 shared voting and dispositive power for each reporting person.

On what share count is the percentage ownership based?

The 7.7% figure is based on 61,759,350 outstanding shares reported by the issuer as of August 1, 2025.

Does the filing indicate an intent to influence control of Monte Rosa?

The signatories certify the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 12:19 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Monte Rosa Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

61225M102

(CUSIP Number)

05/16/2024

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Adam Goulburn

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

AUSTRALIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Zavain Dar

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Nan Li

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Dimension Management, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Dimension Capital I GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Dimension Management GP, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP No. 61225M102

1

Names of Reporting Persons

Dimension Capital I, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,757,563.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,757,563.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,757,563.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Monte Rosa Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 321 Harrison Avenue, Suite 900, Boston, MA 02118
Item 2.
(a)	Name of person filing: The names of the persons filing this report (collectively, the "Reporting Persons") with respect to shares of Common Stock, par value $0.0001 per share (the "Common Stock") of Monte Rosa Therapeutics, Inc. (the "Issuer") are: Adam Goulburn Zavain Dar Nan Li Dimension Management, L.P. ("Dimension Management") Dimension Capital I GP, LLC ("Dimension Capital I GP") Dimension Management GP, LLC ("Dimension Management GP") Dimension Capital I, L.P. ("Dimension Capital I")
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each of the Reporting Persons is 632 Broadway, Suite 801, New York, NY 10012.
(c)	Citizenship: Mr. Goulburn is an Australian citizen. Each of Mr. Dar and Mr. Li is a United States citizen. Each of Dimension Management and Dimension Capital is a Delaware limited partnership. Each of Dimension Capital I GP and Dimension Management GP is a Delaware limited liability company.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 61225M102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 of the cover pages to this Schedule 13G. The ownership percentages reported are based on 61,759,350 outstanding shares of Common Stock as of August 1, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2025. Dimension Capital I directly holds 4,757,563 shares of Common Stock. Dimension Management is the investment advisor to Dimension Capital I, and Dimension Management GP is the general partner of Dimension Management. Dimension Capital I GP is the general partner to the general partner of Dimension Capital I. Mr. Goulburn, Mr. Dar, and Mr. Li are members of each of Dimension Management GP and Dimension Capital I GP.
(b)	Percent of class: The information required by this item with respect to each Reporting Person is set forth in Row 11 of the cover pages to this Schedule 13G.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by this item with respect to each Reporting Person is set forth in Row 5 of the cover pages to this Schedule 13G.
	(ii) Shared power to vote or to direct the vote: The information required by this item with respect to each Reporting Person is set forth in Row 6 of the cover pages to this Schedule 13G.
	(iii) Sole power to dispose or to direct the disposition of: The information required by this item with respect to each Reporting Person is set forth in Row 7 of the cover pages to this Schedule 13G.
	(iv) Shared power to dispose or to direct the disposition of: The information required by this item with respect to each Reporting Person is set forth in Row 8 of the cover pages to this Schedule 13G.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Adam Goulburn

Signature:	/s/ Adam Goulburn
Name/Title:	Adam Goulburn
Date:	10/03/2025

Zavain Dar

Signature:	/s/ Zavain Dar
Name/Title:	Zavain Dar
Date:	10/03/2025

Nan Li

Signature:	/s/ Nan Li
Name/Title:	Nan Li
Date:	10/03/2025

Dimension Management, L.P.

Signature:	/s/ Adam Goulburn
Name/Title:	By: Dimension Management GP, LLC, its general partne; By: Adam Goulburn, Member
Date:	10/03/2025

Dimension Capital I GP, LLC

Signature:	/s/ Adam Goulburn
Name/Title:	Adam Goulburn, Member
Date:	10/03/2025

Dimension Management GP, LLC

Signature:	/s/ Adam Goulburn
Name/Title:	Adam Goulburn, Member
Date:	10/03/2025

Dimension Capital I, L.P.

Signature:	/s/ Adam Goulburn
Name/Title:	By: Dimension Capital I GP, LP, its general partner; By: Adam Goulburn, Member
Date:	10/03/2025

Exhibit Information

99.1 Joint Filing Agreement